Karuna Therapeutics, Inc. (KRTX) Financials
KRTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.3 billion | 82.0 million |
2023-09-30 | 1.4 billion | 62.8 million |
2023-06-30 | 1.5 billion | 52.5 million |
2023-03-31 | 1.5 billion | 28.0 million |
KRTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -111.9 million | 22.8 million |
2023-09-30 | -110.6 million | 18.3 million |
2023-06-30 | -64.9 million | 18.0 million |
2023-03-31 | -101.3 million | 15.5 million |
KRTX Net Income
No data available :(
KRTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.3 billion | - | 16.7 million |
2023-09-30 | 1.3 billion | - | 15.6 million |
2023-06-30 | 1.4 billion | - | 15.8 million |
2023-03-31 | 1.5 billion | - | 4.8 million |
KRTX Shares Outstanding
KRTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 799000 | 82.2 million | 47.4 million | - |
2023-09-30 | 629000 | 104.0 million | 32.3 million | - |
2023-06-30 | 775000 | 92.5 million | 27.4 million | - |
2023-03-31 | 714000 | 85.5 million | 24.3 million | - |
KRTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | 458000 |
2023-06-30 | - | 469000 |
2023-03-31 | 654000 | 327000 |
KRTX
Price: $329.83
52 week price:
Earnings Per Share: -10.94 USD
P/E Ratio: -29.07
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 180800
Market Capitalization: 12.1 billion